Melanoma trials in Argentina

3 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  Dabrafenib and/or Trametinib Rollover Study

  Where

  CABA

  Age

  18 years to 100 years

  People

  100 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT03340506 · EU 2023-509318-13-00
• Phase 1/2Taking people
  A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  Where

  Buenos Aires, Caba, Ciudad Autonoma Buenos Aires, Mar del Plata

  Age

  18 years and over

  People

  680 worldwide

  Run by

  Daiichi Sankyo

  See details and how to joinNCT06330064 · EU 2023-509632-26-00
• Phase 3Taking people
  IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

  Where

  Buenos Aires, Caba, CABA, Córdoba, Viedma

  Age

  18 years and over

  People

  680 worldwide

  Run by

  Immunocore Ltd

  See details and how to joinNCT06112314